VR Adviser, LLC

VR Adviser, LLC latest Q4_2020 13F filings reported $680,145,000 in market value on this 2021-02-12 report date . The portfolio quarterly return is 33.06%. This fund has 25 securities concentrations of 100% weights.

VR Adviser, LLC largest holding is Constellation Pharmaceuticals Inc. with weight of 17.01% and $115,686,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-122020-12-31Q4_202013F-HR25$680,145,00033.06%
2020-11-162020-09-30Q3_202013F-HR22$511,173,00022.40%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
CONSTELLATION PHARMCETICLS ICNSTINCR$115,6860.42%17.01%$28.800.00%4,016,873
OLEMA PHARMACEUTICALS INCOLMABUY$73,8600.00%10.86%$48.080.00%1,536,193
TRILLIUM THERAPEUTICS INCTRILDECR$59,428-0.42%8.74%$14.71-0.44%4,040,000
KINNATE BIOPHARMA INCKNTEBUY$58,5960.00%8.62%$39.780.00%1,473,014
ATHIRA PHARMA INCATHAINCR$57,9381.06%8.52%$34.250.11%1,691,623
ALTIMMUNE INCALTDECR$50,760-0.15%7.46%$11.280.00%4,500,000
KEROS THERAPEUTICS INCKROSINCR$47,4240.83%6.97%$70.540.00%672,306
MARINUS PHARMACEUTICALS INCMRNSBUY$31,5850.00%4.64%$12.200.00%2,588,941
SYNDAX PHARMACEUTICALS INCSNDXINCR$24,8031.69%3.65%$22.240.78%1,115,255
RELMADA THERAPEUTICS INCRLMDDECR$21,437-0.15%3.15%$32.070.00%668,440
KURA ONCOLOGY INCKURAINCR$18,7800.07%2.76%$32.660.00%575,000
VISTAGEN THERAPEUTICS INCVTGNBUY$18,1580.00%2.67%$1.940.00%9,360,000
CELLDEX THERAPEUTICS INC NEWCLDXINCR$14,0160.18%2.06%$17.520.00%800,000
SURFACE ONCOLOGY INCSURFDECR$13,332-0.50%1.96%$9.24-0.63%1,442,895
ACLARIS THERAPEUTICS INCACRSBUY$12,6480.00%1.86%$6.470.00%1,954,932
COGENT BIOSCIENCES INCCOGTBUY$12,2270.00%1.80%$11.230.00%1,088,817
ALIGOS THERAPEUTICS INCALGSBUY$11,1960.00%1.65%$27.650.00%404,906
GALERA THERAPEUTICS INCGRTXINCR$9,39019.11%1.38%$10.2316.77%917,860
SILVERBACK THERAPEUTICS INCORPORATED USD0.0001SBTXBUY$6,9510.00%1.02%$46.340.00%150,000
BCTG ACQUISITION CORPBCTGINCR$5,7200.10%0.84%$11.440.00%500,000
METACRINE INCMTCRDECR$5,452-0.53%0.80%$7.86-0.39%693,673
FIVE PRIME THERAPEUTICS INCFPRXBUY$4,1700.00%0.61%$17.010.00%245,122
BIOATLA INCBCABBUY$3,4010.00%0.50%$34.010.00%100,000
TAYSHA GENE THERAPIES INCTSHAINCR$2,8660.10%0.42%$26.540.00%107,982
VIRIDIAN THERAPEUTICS INCBUY$3210.00%0.05%$16.470.00%19,495
ALX ONCOLOGY HLDGS INCALXOSOLD$00.00%-100.00%$0.000.00%0
CARDIFF ONCOLOGY INC COMCRDFSOLD$00.00%-100.00%$0.000.00%0
FS DEV CORPGMTXSOLD$00.00%-100.00%$0.000.00%0
SOLD$00.00%-100.00%$0.000.00%0
IMV INCIMVSOLD$00.00%-100.00%$0.000.00%0
MARINUS PHARMACEUTICALS INCSOLD$00.00%-100.00%$0.000.00%0
MEDICENNA THERAPEUTICS CORPMDNASOLD$00.00%-100.00%$0.000.00%0
UNUM THERAPEUTICS INCUNUMSOLD$00.00%-100.00%$0.000.00%0